Nihon Kohden

Nihon Kohden is a mission-driven medical device company focused on creating a better future for healthcare through reliable, innovative technology. Its key achievements include pioneering pulse oximetry, recognized as an IEEE Milestone, and building a comprehensive portfolio of monitoring and diagnostic systems trusted in acute care. The company's strategy combines deepening its core hardware expertise in sensing and signal processing with a strategic expansion into integrated digital health solutions and sustainable product development, supported by its stable position as a publicly traded entity on the Tokyo Stock Exchange.

Nihon Kohden's platform is built on deep expertise in biomedical sensing and signal processing, anchored by its pioneering pulse oximetry technology (an IEEE Milestone), and extended across patient monitoring, neuromonitoring (EEG), and cardiovascular diagnostics, now being augmented with integrated digital health solutions.

Nihon Kohden competes against giants like GE HealthCare and Philips in monitoring, and specialized firms in neurology and cardiology. Its advantages are superior reliability in acute care and deep sensor expertise, but it must accelerate its digital offerings to compete with more software-centric ecosystems.